Comparison of the efficacy and safety of caplacizumab versus placebo in thrombotic thrombocytopenic purpura: a meta-analysis and systematic review based on randomized controlled trials

BACKGROUND: We conducted this meta-analysis to investigate the efficacy and safety of caplacizumab in patients with thrombotic thrombocytopenic purpura (TTP). TTP is a potentially fatal disorder characterized by systemic microvascular thrombosis. METHODS: Randomized controlled trials (RCTs) were con...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Bin, Li, Xihong, Xiao, Dongqiong, Raimundo, Rodrigo Daminello, Zhou, Ruixi, Lei, Yupeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279769/
https://www.ncbi.nlm.nih.gov/pubmed/35845542
http://dx.doi.org/10.21037/atm-22-2847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279769/
https://www.ncbi.nlm.nih.gov/pubmed/35845542
http://dx.doi.org/10.21037/atm-22-2847

Ejemplares similares